![Preclinical Evaluation Assesses [11C]Onalespib for Cancer and Brain PET Imaging](https://bioengineer.org/wp-content/uploads/2026/11/stackrss-featured-2645-350x250.jpg)
Preclinical Evaluation Assesses [11C]Onalespib for Cancer and Brain PET Imaging
A preclinical evaluation of the radiolabelled Hsp90 inhibitor onalespib demonstrated tumour binding but revealed rapid metabolism and negligible brain penetration.
Tag: radiolabelled
